Q3 Earnings Put Cognizant's Large-Deal Ramp Thesis to the Test

What happened

Cognizant's Q3 2026 earnings are out, and Zacks is focusing on key metrics versus estimates, which is the first real test of the master report's thesis that large-deal ramps scheduled for June-July 2026 would translate into revenue acceleration in the second half. The master report set explicit checkpoints: whether revenue inflects as large deals ramp and whether Project Leap restructuring costs are contained while adjusted operating margin holds near 16.0-16.2%. Without specific numbers from this article, the digest cannot confirm whether the ramp materialized, but the emphasis on key metrics suggests investors are looking beyond headline EPS to segment growth, RPO conversion, and attrition. The stock's valuation remains undemanding at roughly 11.5x trailing earnings and 6x EV/EBITDA with a net cash balance sheet, providing a cushion if execution stumbles. However, the bear case of Project Leap disrupting delivery and compressing margins becomes more credible if key metrics miss, potentially driving the stock toward the $45 bear scenario.

Implication

Investors should scrutinize Cognizant's Q3 10-Q for evidence that large-deal ramps are converting into revenue: look for sequential revenue growth above the Q1 run-rate and commentary on ramp progress. Project Leap's impact on delivery quality is a key risk; rising attrition above 14% or disclosures of service disruptions would undercut the margin and stock support. If Q3 results show revenue acceleration and adjusted operating margin of at least 16.0%, the base case of $62 and bull case of $75 become more likely, justifying holding or adding near the $52 attractive entry. Conversely, if key metrics like RPO conversion remain weak (near 35% within one year) and margin falls below 16%, the bear case of $45 gains weight and the thesis should be downgraded. Until the specifics are clear, maintain a cautious stance: the stock remains a potential buy, but conviction should be tempered pending confirmation.

Thesis delta

The master report's thesis that CTSH prices a slow-growth franchise with 2H26 catalysts is now at a decision point. Q3 earnings are the first hard data to validate whether large-deal ramps are delivering revenue and whether Project Leap is protecting margins. A strong print reinforces the base and bull cases, while a weak print shifts probability toward the bear scenario.